IntroductionPyogenic liver abscess (PLA) is a potentially life-threatening intra-abdominal infection. Although it was previously well associated with polymicrobial infections, like Escherichia coli and anaerobes, hypervirulent strains of Klebsiella pneumoniae (hvKp) have emerged in recent decades as dominant causative agents, particularly in East and Southeast Asia [1, 2]. These hypervirulent strains exhibit a hypermucoid phenotype, which is due to the capsular serotypes K1 and K2, and virulence factors such as rmpA, magA, and aerobactin. These factors allow them to enhance capsule production, assist in immune evasion, and iron acquisition, and therefore enable them to cause monomicrobial liver abscesses and disseminated infections even in healthy hosts [3].The clinical presentation of an hvKp liver abscess typically includes fever, right upper quadrant pain, nausea, and leukocytosis. Infections with this superbug are notable for their ability to cause metastatic complications such as endophthalmitis, meningitis, or septic pulmonary emboli [1, 4]. While endemic to South Asia, hvKp has increasingly been reported in Western countries and Europe, mostly in patients of Asian ethnicity or with Asian travel history. Over the past few decades, it has also been reported in non-Asian populations without travel history or identifiable risk factors [5].Diagnosis of PLA relies on abdominal imaging with an ultrasound or CT, which reveals unilocular or multiloculated liver lesions, often in the right hepatic lobe [4]. Confirmation is through blood or abscess culture, with the hypermucoid phenotype sometimes identified via the “string test,” where a colony stretched with a loop produces a viscous string >5 mm [5]. Polymerase Chain Reaction (PCR) can further detect molecular patterns of virulent genes such as rmpA and magA in specialized settings [5].Treatment requires prompt initiation of appropriate antibiotics, commonly third-generation cephalosporins, beta-lactam/beta-lactamase inhibitors, or carbapenems in severe cases [6]. Abscesses larger than 3–5 cm or with poor response to medical therapy may benefit from source control with image-guided percutaneous drainage. Based on the clinical and radiological response, treatment duration typically ranges from 4 to 6 weeks [7].Here we report two unique cases of the hypermucoid phenotype of Hypervirulent Klebsiella pneumoniae liver abscess in Caucasian individuals of American origin, in which one is a known diabetic with no history of international travel, Asian food consumption, or animal contact. These cases highlight the changing epidemiology of hvKp and the need for increased clinical vigilance even in immunocompetent populations previously considered low-risk.Case PresentationCase 1: